» Articles » PMID: 38895465

Acetaminophen Overdose Reveals Protease-Activated Receptor 4 As a Low-Expressing but Potent Receptor on the Hepatic Endothelium

Overview
Journal bioRxiv
Date 2024 Jun 19
PMID 38895465
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Aims: Hepatic endothelial cell (EC) dysfunction and centrilobular hepatocyte necrosis occur with acetaminophen (APAP) overdose. The protease thrombin, which is acutely generated during APAP overdose, can signal through protease-activated receptors 1 and 4 (PAR1/PAR4). PAR1 is a high-affinity thrombin receptor that is known to signal on ECs, whereas PAR4 is a low-affinity thrombin receptor, and evidence for its expression and function on ECs is mixed. This study aims to exploit the high levels of thrombin generated during APAP overdose to determine (1) if hepatic endothelial PAR4 is a functional receptor, and (2) endothelial-specific functions for PAR1 and PAR4 in a high thrombin setting.

Methods: We generated mice with conditional deletion(s) of in ECs and overdosed them with APAP. Hepatic vascular permeability, erythrocyte congestion/bleeding, and liver function were assessed following overdose. Additionally, we investigated the expression levels of endothelial PARs and how they influence transcription in APAP-overdosed liver ECs using endothelial Translating Ribosome Affinity Purification followed by next-generation sequencing (TRAPseq).

Results: We found that mice deficient in high-expressing endothelial or low-expressing had equivalent reductions in APAP-induced hepatic vascular instability but no effect on hepatocyte necrosis. Additionally, mice with loss of endothelial and had reduced permeability at an earlier time point after APAP overdose when compared to mice singly deficient in either receptor in ECs. We also found that endothelial PAR1-but not PAR4-can regulate transcription in hepatic ECs.

Conclusions: Low-expressing PAR4 can react similarly to high-expressing PAR1 in APAP-overdosed hepatic ECs, demonstrating that PAR4 is a potent thrombin receptor. Additionally, these receptors are functionally redundant but act divergently in their expression and ability to influence transcription in hepatic ECs.

References
1.
McCuskey R . Sinusoidal endothelial cells as an early target for hepatic toxicants. Clin Hemorheol Microcirc. 2006; 34(1-2):5-10. View

2.
Kalucka J, de Rooij L, Goveia J, Rohlenova K, Dumas S, Meta E . Single-Cell Transcriptome Atlas of Murine Endothelial Cells. Cell. 2020; 180(4):764-779.e20. DOI: 10.1016/j.cell.2020.01.015. View

3.
Jaeschke H, Xie Y, McGill M . Acetaminophen-induced Liver Injury: from Animal Models to Humans. J Clin Transl Hepatol. 2015; 2(3):153-61. PMC: 4521247. DOI: 10.14218/JCTH.2014.00014. View

4.
Kataoka H, Hamilton J, McKemy D, Camerer E, Zheng Y, Cheng A . Protease-activated receptors 1 and 4 mediate thrombin signaling in endothelial cells. Blood. 2003; 102(9):3224-31. DOI: 10.1182/blood-2003-04-1130. View

5.
Rezaie A . Protease-activated receptor signalling by coagulation proteases in endothelial cells. Thromb Haemost. 2014; 112(5):876-82. PMC: 4218909. DOI: 10.1160/TH14-02-0167. View